by Ashley Jordan Ferira, PhD, RDN The latest findings from the landmark Swedish Obese Subjects (SOS) trial demonstrate that bariatric surgery significantly reduces the incidence of female-specific cancers, with the most pronounced cancer risk reductions seen for endometrial cancer and in women with high insulin levels pre-surgery.1-2 The health and economic burdens of obesity in the US, and globally, are immense. Based on the latest 2015-2016 National Health and Nutrition Examination Survey findings from the Centers for Disease Control and…

We know that many health conditions have underlying chronic inflammation that can make disease management and treatment more complex. Inflammatory bowel conditions, such as IBD or Crohn’s Disease are closely related to inflammation. In this short video with Dr. Serhan of Harvard Medical School, Metagenics Institute inquires about the opportunities to treat IBD and Crohn’s Disease with SPMs for resolution of inflammation. In animal models, there are encouraging result on three resolvins: D1; Mar1; and E1. Each of these is…

While SPMs offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease, it is crucial to consider the correct amount of SPM for various clinical conditions. In this short video with Dr. Charles Serhan of Harvard Medical School, MHICN inquires about the correct dose of SPM in humans. Dr. Serhan responds that the correct dosing levels have yet to be established fully. Questions that remain include: does gender play a role? Does age play a…

Specialized Pro-Resolving Mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. The precursors to SPMs are Omega-3 essential fatty acids, EPA and DHA. In this short video with Dr. Charles Serhan of Harvard Medical School, MHICN inquires about whether it is possible for humans have excessive intake of SPMs. Dr. Serhan responds no as SPM operate under  a feed forward mechanism. 11. Insights from the Metagenics Lifestyle Summit 2015: Charles Serhan, PhD

Specialized Pro-Resolving Mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. Inflammation exists in other settings as well, such as pre- and post-operative settings where healing will be necessary. Metagenics Institute asks Dr. Charles Serhan of Harvard Medical School if there is any data regarding pre- and post-operative use of SPMs for improved healing outcomes. Dr. Serhan responds that there is, indeed, data supporting that indication of SPMs. SPMs will not interfere…

Specialized Pro-Resolving Mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. In this short video, we ask Dr. Charles Serhan of Harvard Medical School about the time of onset of action for SPMs following their ingestion. Dr. Serhan responds that, in a limited study of humans, the conversion of substrate is very fast. Within four hours, investigators could identify those patients who had taken pro-resolving mediators by testing the peripheral blood. Experiments…

Specialized Pro-Resolving Mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. In this short video, Metagenics Institute asks Dr. Charles Serhan of Harvard Medical School about some parameters or markers that can be used to assess the efficacy of SPMs. Dr. Serhan responds that indices have been created to measure SPMs. Current tools include assessing pre- and post- levels of SPMs in blood, as well as the functional increase related to certain…

Specialized Pro-Resolving Mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. In this short video, we ask Dr. Charles Serhan of Harvard Medical School about some situations under which SPM biosynthesis would be challenged. More specifically, what pharmacological interactions would make SPMs and inflammation resolution less effective? Dr. Serhan responded that a variety of pharmaceuticals have been tested with SPMs. It may be surprising that NSAIDs, which reduce the signs and symptoms…

by Ashley Jordan Ferira, PhD, RDN Cellular oxidative stress, the balance between pro-oxidants and antioxidants, may contribute to the pathogenesis of chronic diseases.1 A nutrient-dense dietary pattern, particularly one containing fruits and vegetables, whole grains, nuts, and legumes, confers antioxidant activity in the body. This is important because prior research has demonstrated that increasing the amount of antioxidants in the diet is associated with reductions in cardiovascular disease (CVD), cancer and all-cause mortality.1 However, data linking antioxidant intake and effects…

by Ashley Jordan Ferira, PhD, RDN The global burden of diabetes is staggering, with an estimated 422 million adults living with the chronic disease.1 This prevalence has almost doubled since 1980 alongside the rise in obesity and has been dubbed the “diabesity” phenomenon.1 Diabetes and its myriad comorbidities (heart attack, stroke, kidney disease, nerve damage, limb amputation, vision loss, and pregnancy complications) translate into substantial economic losses to the person affected by the disease, health systems and national economies.1 Effective…